The current paradigm of cyclin-dependent kinase (CDK) regulation based on the well-established CDK2 has been recently expanded. The determination of CDK9 crystal structures suggests the requirement of an additional regulatory protein, such as human immunodeficiency virus type 1 (HIV-1) Tat, to exert its physiological functions. In most kinases, the exact number and roles of the cofactor metal ions remain unappreciated, and the repertoire has thus gained increasing attention recently. Here, molecular dynamics (MD) simulations were implemented on CDK9 to explore the functional roles of HIV-1 Tat and the second Mg 2 + ion at site 1 (Mg 1 2+ ). The simulations unveiled that binding of HIV-1 Tat to CDK9 not only stabilized hydrogen bonds (H-bonds) between ATP and hinge residues Asp104 and Cys106, as well as between ATP and invariant Lys48, but also facilitated the salt bridge network pertaining to the phosphorylated Thr186 at the activation loop. By contrast, these Hbonds cannot be formed in CDK9 owing to the absence of HIV-1 Tat. MD simulations further revealed that the Mg 1 2+ ion, coupled with the Mg 2 2+ ion, anchored to the triphosphate moiety of ATP in its catalytic competent conformation. This observation indicates the requirement of the Mg 1 2+ ion for CDK9 to realize its function. Overall, the introduction of HIV-1 Tat and Mg 1 2+ ion resulted in the active site architectural characteristics of phosphorylated CDK9. These data highlighted the functional roles of HIV-1 Tat and Mg 1 2+ ion in the regulation of CDK9 activity, which contributes an important complementary understanding of CDK molecular underpinnings.
Introduction
Cyclin-dependent kinase 9 (CDK9) is a Ser/Thr kinase that belongs to the family of cyclin-dependent kinases (CDKs). CDK9 serves as the catalytic subunit of the positive transcription elongation factor b (P-TEFb; CDK9/cyclin T), which phosphorylates the RNA polymerase II C-terminal domain and the negative elongation factors NELF and DRB (dichlorobenzimidazole riboside)-sensitivity-inducing factor (DSIF) to trigger the elongation of many gene transcripts [1] . P-TEFb has been an important therapeutic target in oncology, virology, and cardiology [2, 3] . A viral protein, human immunodeficiency virus type 1 (HIV-1) Tat, interacts with P-TEFb and induces the factor to promote the productive elongation of HIV mRNA [4] [5] [6] . Biochemical experiments have shown that Tat increased transcriptional elongation performed by CDK9 [7] .
Twenty CDK9 crystal structures have thus far been solved [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] , and their availability serves as a valuable resource for structure-aided drug design. CDK9 adopts a typical bilobal fold (Fig 1A) , which is extremely conserved among Ser/Thr and Tyr kinases. The N-terminal lobe is composed of a five-stranded antiparallel β-sheet and one prominent α-helix, i.e., the helix αC (sequence PITALRE in CDK9 and PSTAIRE in CDK2). The larger C-terminal lobe is mostly helical and connected to the N-terminal lobe by the so-called flexible hinge region (residues 104-107). ATP is sandwiched between the N-and C-terminal lobes and anchors its adenine moiety by H bonds with Asp104 and Cys106 in the hinge region. Cyclin T has a canonical cyclin structure. The interface of CDK9/cyclin T is notably smaller than that of the CDK2/cyclin A complex and is restricted to the N-terminal lobe of CDK9.
Although a few kinases are known to harness a single divalent ion or none at all [19] , many, if not all, protein kinases require two divalent metal ions for optimum catalysis [20] . In the kinome, the exact number and roles of the cofactor metal ions remain unknown, and the repertoires have recently gained increasing attention. Thus far, a few CDK9 crystal structures are associated with a single Mg 2+ ion at site 2 (Mg 2 2+ ion; Fig 1A and 1B) , whereas the other Mg 2+ ion at site 1 (Mg 1 2+ ion) is absent in all CDK9 crystal structures. The crystal structures of CDK2 with two Mg 2+ ions had not been solved until recently, when the crystal structures of CDK2/cyclin A transition state (TS) complex with two Mg 2+ ions were discovered by Yong et al. [21, 22] . Experimental observations have demonstrated that Mg 2+ concentration could represent an important regulator of CDK2 activity in vivo [21] . These findings raise an interesting question on whether CDK9 requires the binding of two Mg 2+ ions to realize its function, as in the case of CDK2. CDK2 is a phenotypic family of CDKs. A series of CDK2/cyclin A structures have provided significant insight into the molecular underpinnings of CDK activation and regulation. The need of CDKs to be associated with a cognate cyclin, followed by phosphorylation on threonine at the activation loop to realize full activity, is well-documented [23, 24] . However, the generality of this underlying mechanism has been challenged with the determination of new CDK crystal structures. For instance, the crystal structures of CDK4/cyclin D revealed that cyclin D binding and activation loop phosphorylation do not adequately enable the CDK4 to adopt an active conformation [24, 25] . In fact, recent experiments underscored that association with additional protein substrates and/or cofactor binding are critical to the remodeling of CDK4/cyclin D into its active conformation [25] [26] [27] . Additionally, the solved CDK9/cyclin T crystal structures demonstrated some notable structural differences in the phosphorylated Thr186 (pThr186) at the activation loop. Although the phosphorylation of Thr186 is required for CDK9 activation [28] , pThr186 in CDK9/cyclin T1 complex crystal structures only forms salt bridge interactions with Arg148 and Arg172. This condition is unlike that the CDK2/cyclin A complex, in which pThr160 forms salt bridge interactions with the positively charged triad of arginine residues (Arg50, Arg126, and Arg150). pThr186 is slightly distant (3.9 Å) from the third arginine residue (Arg65), which is located in the αC helix ( Fig 1A) [8] . Interestingly, as shown in Fig 1B, the crystal structure of CDK9/cyclin T1 in a complex with a minimal activation domain (residues 1-48) of HIV-1 Tat formed five salt bridges with the arginine triad [9] .
HIV-1 Tat, a two-zinc-mediated viral transactivator of transcription, inserts itself into a groove at the heterodimer interface, thus augmenting interactions and resulting in a more stable P-TEFb complex. The reestablished Arg65-pThr186 ion pair results in a more stable local conformation and contributes to maintaining strong contact between the critical activation loop and the prominent αC helix motif. The current understanding of kinase regulation owes much to X-ray crystallography [29] . In this study, we performed 50 ns explicit-solvent MD simulations on five different systems to determine the influence of HIV-1 Tat binding, activation loop phosphorylation, and the presence of Mg 1 2+ at site 1 on CDK9 dynamics. Our results revealed elaborate and significant differences in the dynamics behavior of CDK9, which provides insight into the current understanding of CDK regulation and may contribute to structure-based drug design.
Materials and Methods

Initial Complexes Preparation
The crystal structure of phosphorylated CDK9/cyclin T1 complex bound to ATP and one Mg 2 + ion at site 2 (Mg 2 2+ ion) (pCDK9/cyclin T1/ATP/1MG complex) was obtained from the RCSB Protein Data Bank (PDB code 3BLQ) [8] (Fig 1A) . The first four simulation systems were based on this crystal structure. The missing Mg 2+ ion at site 1 (Mg 1 2+ ion) was modeled into its position by aligning the crystal structure of GSK3β in the complex with ATP analog adenosine 5 0 -(β,γ-imidotriphosphate) (AMP-PNP) and two Mg 2+ ions (PDB code 1PYX) [30] with the pCDK9/cyclin T1/ATP/1MG complex crystal structure. The Mg 1 2+ ion is and subsequently extracted to model the pCDK9/cyclin T1/ATP/2MG complex. The pThr186 at the active loop of the two complexes was replaced with nonphosphorylated Thr186 to construct the CDK9/cyclin T1/ATP/1MG and CDK9/cyclin T1/ATP/2MG complexes. The fifth simulated complex was based on another crystal structure of pCDK9/cyclin T1 in the complex with AMP-PNP and Mg 2 2+ ion and the minimal activation domain (residues 1-48) of HIV-1 Tat (pCDK9/cyclin T1/AMP-PNP/1MG/Tat complex; PDB code 3MIA) [9] (Fig 1B) . The missing Mg 1 2+ ion in the X-ray structure results in the lack of a coordination bond between the ATP O γ atom and Mg 1 2+ ion, which causes the γ-phosphate of AMP-PNP to assume an unusual conformation. Therefore, the crystal structure of the GSK3β/AMP-PNP/2MG complex was also aligned with the crystal structure of the pCDK9/cyclin T1/AMP-PNP/1MG/Tat complex to extract both AMP-PNP and Mg 1 2+ ion coordinates into the pCDK9 ATP binding pocket. The imido nitrogen atom was subsequently replaced with the oxygen atom, thus generating the pCDK2/cyclin T1/ATP/2MG/Tat complex. The missing residues in the two CDK9 X-ray structures were completed using Molecular Operating Environment [31] and further minimized by AMBER 11 [32] in the subsequent procedure. The detailed compositions of the five initial complexes are summarized in Table 1 . The Roles of HIV-1 Tat and a Second Magnesium Ion in the CDK9/CyclinT1
Force Field
The AMBER force field (ff99SB) [33] was applied to the CDK9 protein, cyclin T1 protein, HIV-1 Tat protein, and Mg 2+ ions. Glu/Asp residues were deprotonated and Lys/Arg residues were protonated at a simulated pH of 7. The protonated states for the His residues were assigned according to the PROPKA calculation, with the exception of the involvement of those in the coordination with the zinc ion [His33 in the HIV-1 Tat coordinated to the zinc ion was modeled as a negative charge state (−1 charge)]. We adopted the cationic dummy atom approach introduced by Pang et al. [34, 35] to describe the zinc divalent cation. This approach places four cationic dummy atoms in a tetrahedral arrangement in the zinc nucleus to mimic the 4s4p 3 vacant orbitals of the zinc ion. Thus, the lone-pair electrons of the zinc coordinates occupy the vacant orbitals and fulfill the orientation requirements for the tetrahedral coordination geometry of zinc. The zinc nucleus was assigned with only van der Waals parameters (van der Waals r Ã = 3.1 Å, van der Waals potential well depth ε = 1E-6 kcal/mol, and charge q = 0), whereas the dummy atom was assigned only with charge (r Ã = 0, ε = 0, and q = 0.5e). The force field parameters for the -2 charged pThr186 and the -4 charged ATP were taken from the AMBER parameter database [36, 37] .
MD Simulations
The hydrogen atoms and the missing atoms were added to the Leap module of AMBER 11 [32] . Each system was immersed in the truncated octahedron box of TIP3P [38] water molecules with a 10 Å buffer in each direction. An appropriate number of Cl -counterions were then added through the random substitution of solvent water molecules with Cl -ions at the most favorable electrostatic potential positions to maintain the electroneutrality of the five systems. Thus, the total number of atoms for Systems 1, 2, 3, 4, and 5 were 68110, 68297, 68308, 68309, and 93339, respectively. Energy minimizations and MD simulations were conducted using the SANDER module of AMBER 11 with periodic boundary conditions. Prior to the production run, each system was optimized by using three steps minimization. First, ATP, metal ions, and protein residues were fixed with harmonic force restraint, and only the positions of the water molecules were minimized. Second, ATP, metal ions, and protein residues from crystal structures were constrained, whereas the added missing residues and water molecules were minimized. Finally, the whole system was allowed to fully relax. In each step, energy minimization was performed using the steepest descent method for the first 2500 steps and the conjugated gradient method for the next 2500 steps. Each system was then gradually raised from 0 K to 300 K in a 50 ps canonical ensemble (NVT) heating process. Finally, 50 ns production MD simulations were performed on the five systems in an isothermal isobaric ensemble (NPT) at a constant pressure (1 atm) and constant temperature (300 K) by applying the Langevin algorithm [39] . A cutoff equivalent to 10 Å was set for short-range electrostatics and van der Waals interactions. Long-range electrostatic interactions were processed using the particle mesh Ewald method [40] with cubic fourth-order B-spline interpolation and a 10 -5 tolerance set for the direct sum tolerance. An integration step of 2 fs was set for the MD simulations. All covalent bonds involving hydrogen atoms were constrained at their equilibrium positions by the SHAKE method [41] with a tolerance of 10 -5 Å.
All the MD trajectories were subsequently analyzed using PTRAJ module. The 1 ps interval saved coordinates were used to obtain the root-mean-square deviations (RMSDs), to calculate the change in distance between two atoms, and to analyze H bonds. The criteria for forming an H bond consists of an angle A-H-D larger than 120°and a distance between the acceptor atom and the donor atom smaller than 3.5 Å.
Dynamic Cross-correlation Matrices
The Cα dynamic cross-correlation matrices (DCCM) were computed to reveal the correlative motions of proteins [42] . C(i,j) was calculated as follows:
Cði; jÞ ¼ cði; jÞ cði; iÞ 1=2 cðj; jÞ
1=2
where C(i,j) is the covariance matrix element of the protein fluctuation between residues i and j. The value of C(i,j) ranges from -1 to 1. Positive values suggest positively correlated movement (the same direction), whereas negative values suggest anticorrelated movement (the opposite direction).
Results
System Stabilities during MD Simulations
Conventional MD simulations of five systems, CDK9/cyclin T1/ATP/1MG complex (System 1), pCDK9/cyclin T1/ATP/1MG complex (System 2), CDK9/cyclin T1/ATP/2MG complex (System 3), pCDK9/cyclin T1/ATP/2MG complex (System 4), and pCDK9/cyclin T1/ATP/ 2MG/Tat complex (System 5), were performed in explicit water for 50 ns. The Cα atom RMSDs of the CDK9/cyclin T1 complexes in relation to the initial minimized structures as a function of simulation time for five systems were monitored. As shown in Fig 2, after approximately 10 ns of simulation, the RMSDs tended to converge in Systems 1, 2, 3, 4, and 5 with values of 3.07 ± 0.37 Å, 2.71 ± 0.30 Å, 3.18 ± 0.25 Å, 2.95 ± 0.31 Å, and 2.94 ± 0.30 Å, respectively. These values, along with the time dependence of total energies (data not shown), indicate that the five systems achieved a state of equilibrium and were sufficient for exploring the dynamic behavior of the studied systems. 
Salt Bridge Network in the pThr186 Binding Site
Thr186 at the active loop is phosphorylated in three constructed simulation systems (Systems 2, 4, and 5). A cluster of three arginine residues, including Arg65 at the αC helix, Arg148 at the catalytic loop, and Arg172 at the activation loop, constitutes the pThr186 binding site. System 5 contains HIV-1 Tat and features two salt bridges that were formed by Arg65 and Ary148 and one salt bridge that was formed by Arg172. Negatively charged pThr186 served as the hub to organize the positively charged triad. All five salt bridges were very stable throughout the simulation time (Fig 3C) . By contrast, in Systems 2 and 4 without HIV-1 Tat binding, the resulting salt bridge networks were less stable. For example, in System 4, only one salt bridge was formed by Arg65, and it was less stable than that in System 5 ( Fig 3B) . In the System 2, the salt bridge formed between pThr186 and Arg65 was weakest (Fig 3A) . Taken together, these data indicate that both Mg 1 2+ ion and HIV-1 Tat contributed to the stability of the salt bridge network formed by pThr186.
Hydrogen Bonds in the ATP Binding Pocket
The hydrogen bonds formed by ATP with CDK9 are shown in Fig 4 and 
ATP Conformation in the ATP Binding Pocket
Apart from the differences in the formation of H bonds between ATP and CDK9 in various systems, the simulations also indicated that the binding of both the We also analyzed the conformational change in the triphosphate moiety of ATP by monitoring the dihedral O α3 -P β -O β3 -P γ and the distance between the P α and P γ atoms in the five simulation systems as a function of time (Fig 6B and 6C) . respectively). The distances between the P α and P γ atoms were 3.78 ± 0.08 Å, 3.94 ± 0.07 Å, 3.99 ± 0.06 Å, 4.24 ± 0.06 Å, and 4.31 ± 0.06 Å in Systems 1, 2, 3, 4, and 5, respectively. In Systems 1 and 2, which lacked the Mg 1 2+ ion, the dihedral angle O α3 -P β -O β3 -P γ and the distance between the two phosphorus atoms (P α and P γ ) were significantly different from those observed in the binding systems with two Mg 2+ ions.
Magnesium-Ligand Coordination
To analyze the magnesium-ligand coordination mode in our simulations, we compared our simulation results with the X-ray crystal structures of CDK2. Yong et al. recently obtained several ADP cocrystallized pCDK2/cyclin A structures [21, 22] . Two of these structures comprise pCDK2/cyclin A bound to ADP, substrate peptide, and trigonal-planar MgF 3 -ion, a mimic for the γ-phosphate of ATP (PDB code 3QHR and 3QHW), which are very similar to the TS complexes. Two crystal structures (Fig 7B and 7C) showed Mg 1 2+ ions that were coordinated by one of the MgF 3 -fluorine atoms, an ADP β-phosphate oxygen atom, two side chain carboxyl oxygen atoms of Asp145 at the DFG motif, and oxygen atoms of two water molecules. Mg 2
2+
ion also formed six coordination bonds with one of the MgF 3 -fluorine atoms, ADP α-and β-phosphate oxygen atoms, one carboxyl oxygen atom of Asp145, one side chain carbonyl oxygen atom of Asn132, and one oxygen atom of water molecule. Each Mg 2+ ion maintained a hexa-coordinated octahedral geometry, which was also observed in the pCDK2/cyclin A complex bound to ADP with one Mg 2+ ion (PDB code 4II5) or with two Mg 2+ ions (PDB code 4I3Z), as shown in Fig 7D and 7E , respectively. The difference is that the coordinated MgF 3 -fluorine atom in the 3QHR and 3QHW is replaced by the oxygen atom of water molecule in the 4II5 and 4I3Z. In simulation System 5 (Fig 7A) , the Mg 1 2+ ion also formed six coordination bonds with ATP β-and γ-phosphate oxygen atoms, two side chain carboxyl oxygen atoms of invariant Asp167 (Asp145 in CDK2) of the DFG motif, and two oxygen atoms of water molecules. Compared with Mg 1 2+ ion in the two CDK2 TS complex X-ray structures, five coordination bonds were found to be similar, and only one coordination bond was different, that is, the γ-phosphate oxygen acted as a coordinating group in place of fluorine in MgF 3 -.
An Mg 2 2+ ion also exhibits hexa-coordinated octahedral geometry, but only five coordination bonds were observed during simulation. Mg 2 2+ was coordinated to ATP α-and γ-phosphate oxygen atoms, a carboxyl oxygen atom of Asp167 (Asp145 in CDK2), a side chain carbonyl oxygen of Asn154 (Asn132 in CDK2), and an oxygen atom in water. In this work, the γ-phosphate oxygen, instead of β-phosphate oxygen, is a coordinating group, and an unoccupied coordination position is observed. This position is occupied by fluorine ion in MgF 3 -in the CDK2 TS complex. All three solvent water molecules involved in the coordination at the ATP binding pocket rapidly reached their equilibrium positions at the beginning of the simulation in System 5 and remained at their equilibrium positions at the end of 50 ns simulation, but no water molecule filled the unoccupied coordination position. This condition may be attributed to the fact that the unoccupied position is required for CDK9 to achieve its TS. A possible scenario is that the β-phosphate oxygen atom will form a coordination bond with Mg 2 2+ , whereas the cleaved γ- ) formed six coordination bonds, similar to that observed in the three CDK2 crystal structures (Fig 7) . Lu et al. [43, 44] showed that the hexa-coordinated octahedral geometry of Mg 2+ ion at site 1 was important for GSK3β activity, and dislodging this natural cofactor Mg The Roles of HIV-1 Tat and a Second Magnesium Ion in the CDK9/CyclinT1 ion by a nonnative Ca 2+ ion, which preferred a hepta-coordinated geometry, eliminated enzymatic activity.
Critical Conformational Change
We superimposed the CDK9 subunit in pCDK9/cyclin T1/ATP/2Mg/Tat complex of System 5 with the CDK9 subunit in the other four systems to explore the critical conformation change of CDK9, which results in the nonproductive binding of ATP. Upon closer inspection, the prominent helix αC, a key structural element, was shifted in non-HIV-1 Tat binding systems. As shown in Fig 8D , the unoccupied space above the activation loop in System 4 caused the activation loop to rotate upward, followed by the upward shift in the helix αC. As a consequence of this conformational change, the position of two conserved hydrogen-bond interacting residues (Glu66 and Lys48) that are important for the correct localization of ATP triphosphate were relocated, which consequently caused Lys48 to form different H bonds with ATP. Systems 3 and 4 showed that Lys48 H bonds with O α1 and N 7 atoms instead of forming H bonds with O α1 and O β2 atoms, as is the case in System 5. In the one Mg 2+ binding systems, the location and conformation of ATP were altered to a greater degree than those in the two Mg 2+ binding systems. The absence of Mg 1
2+
, ATP β-phosphate, and γ-phosphate oxygen atoms in Systems 1 and 2 were rotated and displaced, which were also demonstrated by the significant differences in RMSDs of the triphosphate moieties and the dihedral angles O α3 -P β -O β3 -P γ . In System 1, the helix αC moved forward instead of exhibiting the upward shift observed in the other three systems. The side chain of Arg65 was curled in the nonphosphorylated systems, possibly because of charge repulsion.
Discussion
Phosphorylation of the activation loop is a prerequisite for kinase activation [45, 46] . The ion pairs between Arg65 and pThr186 in CDK9, between Arg50 and pThr160 in CDK2, and between His87 and pThr197 in catalytic subunit of PKA (PKAc) [47] , which connect the activation loop of the C terminal lobe and helix αC of the N terminal lobe, are key structural elements of active kinases. A more stable salt bridge network between pThr186 and the arginine triad was formed in the presence of the HIV-1 Tat binding system. Notably, cyclin T1 in the first four systems was based on one crystal structure (PDB code 3BLQ) [8] , which included three point mutations at residues Q77R, E96G, and F241L. By contrast, cyclin T1 in the last system is based on a different crystal structure (PDB code 3MIA) [9] and is a wild-type protein.
Among the three mutations, E96G is located at the CDK/cyclin interface, and Glu96 T1 was found to form salt bridge interactions with Arg65 CDK9 in System 5. To investigate the function of Glu96 T1 in the formation of Arg65-pThr186 ion pairs, we checked the twenty CDK9/cyclin T1 crystal structures in the PDB database. Only seven of them contained wild-type Glu96 in cyclin T1. The crystal structures of seven CDK9/cyclin T1 complexes are listed in S1 Table and the salt bridge network formed by Glu96 T1 , Arg65 CDK9 and pThr186 CDK9 are shown in S1 Fig. Two Arg65-pThr186 ion pairs were observed in the four crystal structures with Tat binding (PDB code 3MIA [9] , 3MI9 [9] , 4OGR [17] , and 4OR5 [18] ). The CDK9/cyclin T1 complex binding to AFF4 scaffold (PDB code 4IMY [11] ) showed the existence of an Arg65-pThr186 ion pair. In other non-Tat binding crystal structures, only one Arg65-pThr186 ion pair was found in the crystal structure (PDB code 3TNH [10] ), and no ion pair was detected in the other crystal structure (PDB code 3TNI [10] ). These data from crystal structures are consistent with our MD simulation results, which suggested that only one less stable Arg65-pThr186 salt bridge was formed in the complex owing to the absence of Tat binding. Schulze-Gahmen et al. [11] have recently found that although HIV-1 Tat increases P-TEFb affinity for AFF4 scaffold, the structure of CDK9 kinase subunit structure did not show significant change upon AFF4 binding to P-TEFb and further addition of AFF did not stimulate the kinase activity of Tat-P-TEFb complex. Taken together, these results demonstrate that the Glu96 in the cyclin T1 may contribute to the reorientation of the side chain of Arg65, but does not significantly affect the interaction between Arg65 and pThr186. Therefore, HIV-1 Tat binding contributed to the formation of a stable salt bridge network.
Although the conformation differences between the structures of pCDK9/cyclin T1/ATP/ 1MG complex (PDB code 3BLQ) and pCDK9/cyclin T1/AMP-PNP/1MG/Tat complex (PDB code 3MIA) were minor (RMSD = 1.220 Å), significant differences in dynamic behavior were observed in the last two systems. Both the wild-type and triple mutant complexes have the same K Mapp'ATP value determined by Baumli et al. [10] , which indicated that ATP binding was unaffected by mutation. Therefore, the different dynamic behavior of Systems 4 and 5 can be attributed to HIV-1 Tat binding. Repositioning of the helix αC is widely exploited to explore the modulation of protein kinase activities. In this work, the shift of helix αC caused Glu66 and its partner Lys48 to assume incorrect positions, thereby leading to the disruption of H bonds between Lys48 N z atom and ATP O β2 atom.
The presence of Mg 1
2+
, along with regulator HIV-1 Tat binding, accounted for the extremely similar architecture in CDK9 as that observed in some other kinase crystal structures containing two metal ions and nonhydrolyzable ATP analog (or ADP). These structures include pCDK2/cyclin A/ADP/2MG/MgF 3 -/peptide complex (PDB code 3QHR [21] ), GSK3β/ AMP-PNP/2MG complex (PDB code 1PYX [30] ), MST3/ADP/2MN complex (PDB code 3A7J [48] ), PKAc/AMP-PCP/2MG complex (PDB code 4IAC [49] ), PKB/AMP-PNP/2MN complex (PDB code 1O6L [50] ) and p38γ/AMP-PNP/2MG complex(PDB code 1CM8 [51] ) (S2 Table) . Many enzymes catalyze similar reactions that release the γ-phosphate from a nucleotide triphosphate (NTP), but the number of catalytic metals is not always conserved. Myosin [52] [53] , elongation factor Tu [54] and TIP49 AAA+ ATPase [55] have different ATP binding mode and ATP hydrolysis mechanism is involved in a single Mg 2+ ion. Also, there are two metal ions captured in several crystal structures of catalytic subunit of cAMP-dependent kinase (PKAc), including the reactant, PKAc/ATP/2MG complex (PDB code 4IAC [49] ), the product, PKAc/ ADP/2MG complex (PDB code 4IAD, 4IAF [49] ), and the transition state analog, PKAc/ADP/ AlF 3 /substrate peptide/2MG complex (PDB code 1L3R [56] ). In the transition state of PKAc (S3A Fig), the arrangement of the side chain oxygen atom of Ser in the substrate peptide (OγSer-P), Al 3+ ion and the oxygen atom of β phosphate is in line. In PKAc, the transition states of the phosphoryl-transfer reaction have been classified as associative or dissociative transition states. In the associative mechanism, one of the oxygen atoms of the γ phosphate group to be transferred acts as a base, accepting the proton initially attached to OγSer-P [57] .
In the dissociative mechanism, Asp166 residue serves as a catalytic base that accepts substrate peptide proton during the phosphorylation process [58] [59] [60] . Although there are two disputed phosphoryl-transfer mechanisms, OγSer-P has to attack ATP γ phosphorus in S N 2-like reaction, producing the direct displacement of the ADP moiety, without the involvement of any solvent water. Alignment of the MD snapshot of System 5 with PKAc transition state analog is shown in S3C Fig The triphosphate moiety binding subpocket is extremely electronegative and includes a number of conserved negative charges, such as Glu66 (Glu51 in CDK2), Glu149 (Glu127 in CDK2), and Asp167 (Asp145 in CDK2 (Fig 9A and 9C ) and the phosphorylated states of CDK9 (Fig 9B, 9D and 9E ) revealed that the nonphosphorylated states of CDK9 displayed stronger anticorrelated motions than the phosphorylated states of CDK9. These results indicate that phosphorylation of CDK9 has the potential to stabilize the conformational plasticity of CDK9. A comparison between the one Mg 2+ ion binding (Fig 9A) and the two Mg 2+ ion binding systems (Fig 9C) showed that the two Mg 2+ ion binding system significantly reduced the conformational motions relative to the one Mg 2+ ion binding system. However, this effect was not obviously observed in the phosphorylated states of CDK9 with one Mg 2+ ion binding ( Fig 9B) and two Mg 2+ ion binding systems (Fig 9D) . In addition, when compared with to the structure without HIV-1 Tat (Fig 9D) , binding of HIV-1 Tat to the CDK9/cyclin T1 complex reduced the conformational motions of complex (Fig 9E) . Cumulatively, these data suggest that the phosphorylated state of CDK9, the second Mg 2+ ion, and HIV-1 Tat binding are capable of stabilizing the conformational flexibility of complexes.
Conclusions
The present MD simulations provided valuable insight into the functional roles of regulator HIV-1 Tat and a second Mg 2+ ion at site 1. HIV-1 Tat binding was is important to stabilize the salt bridge network in the pThr186 binding site. HIV-1 Tat binding also occupied the space above the activation loop, hence blocking upward shift of the activation loop. The strong Arg65-pThr186 ion pair and steric hindrance fixed the prominent helix αC in its appropriate position, which consequently resulted in the correct location of the highly conserved glutamate residue Glu66 and its partner Lys48. The second Mg 2+ ion at site 1 was required for CDK9 to realize its function. The ion had a crucial role to fix the triphosphate moiety in its appropriate position by establishing coordination bonds with β-and γ-phosphate oxygen atoms. HIV-1 Tat binding, along with the appearance of two Mg 2+ ions, resulted in an optimized The Roles of HIV-1 Tat and a Second Magnesium Ion in the CDK9/CyclinT1 magnesium-ligand coordination mode and the reproduction of the active site architectural characteristics in phosphorylated CDK9. The ATP binding mode in CDK9, which involves H bonds between the adenine moiety of ATP and hinge region residues, H bonds formed by the conserved residue Lys48 with the O α1 and O β2 atoms of ATP, and the hexa-coordinated octahedral geometry of Mg 2+ with conserved residues Asp167 (Asp145) and Asn154 (Asn132), is very similar to the conformation captured in crystal structures of the pCDK2/cyclin A TS complex. All these results provide significant insight into the CDK activation/regulation processes and might help with the design of P-TEFb inhibitors to target HIV-1 transcription.
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